The Japanese government decided at a cabinet meeting Friday to put a special law to combat new highly virulent strains of influenza into effect on Saturday, in the face of the spread of the H7N9 bird flu strain in China, which has reportedly killed 10 people.
After the law becomes effective, the government will present a draft action plan that includes steps to prevent infections as well as medical measures to a panel of experts on Tuesday.
Based on the action plan, which is expected to be finalized in late May at the earliest, prefectural governments will draw up more concrete plans to deal with new-flu spread.
Of the new network news Japan's National Institute of Infectious Diseases confirmed that Japan there are four kinds of medicine for the treatment of this new type of influenza effect.
According to Japanese news network reported on April 13, MHLW announced that Japan's National Institute of Infectious Diseases After the virus of the H7N9 strain of bird flu from China sample analysis to confirm Japan there are four kinds of medicine for the treatment of this new type of influenza effect.
Health Ministry sources said after the pathological test virus on one of the patients, found a better therapeutic effect. These four effective drug Tamiflu, Relenza Inavir and Rapiacta (, or peramivir). At present, Japan's total reserves of 6322 million copies of these drugs.
The H7N9 strain of bird flu virus samples from China arrived in Japan in the 11th. Japan's National Institute of Infectious Diseases has been the basis of this sample began producing 100 inspection body, in order for the International Airport and the main ports of the epidemic prevention and quarantine institutions. The institute said that once the suspect can determine whether it is the H7N9 avian influenza within 6 hours.